Wootton Bethany M, Hunn Alexandra, Moody Annabelle, Lusk Bethany R, Ranson Valerie A, Felmingham Kim L
Discipline of Clinical Psychology,Graduate School of Health,University of Technology Sydney,Ultimo,2007,Australia.
Department of Medicine (Psychology),University of Tasmania,Locked Bag 30,Hobart,TAS,7001,Australia.
Behav Cogn Psychother. 2018 Nov;46(6):690-705. doi: 10.1017/S1352465818000267. Epub 2018 Apr 25.
Social anxiety disorder (SAD) is a common and chronic mental health condition. Given the significant prevalence and impairment caused by SAD, it is important to investigate novel ways to improve the efficacy of cognitive behavioural therapy (CBT) for SAD. One approach may be to provide CBT in an accelerated fashion, which involves multiple sessions per week. Such accelerated treatments have been shown to be effective in other anxiety disorders, but in SAD this accelerated treatment has only been studied in a group treatment format.
The aim of this study was to provide a preliminary investigation of the efficacy of individual accelerated CBT (aCBT) in the treatment of SAD.
The studied utilized an open trial design. Seventeen participants commenced the treatment, which consisted of 12 sessions delivered over 4 weeks.
The results indicated that participants obtained moderate to large effect sizes on measures of SAD at post-treatment (range d = 0.76-0.92) and 3-month follow-up (range d = 1.31-1.79). In addition, at post-treatment, 59% of participants no longer met criteria for SAD, and this number increased to 71% at 3-month follow-up.
The results provide preliminary evidence to suggest that individual aCBT may be an important treatment option for individuals with SAD.
社交焦虑障碍（SAD）是一种常见的慢性心理健康状况。鉴于SAD造成的显著患病率和损害，研究提高SAD认知行为疗法（CBT）疗效的新方法很重要。一种方法可能是以加速方式提供CBT，即每周进行多次治疗。这种加速治疗在其他焦虑症中已被证明是有效的，但在SAD中，这种加速治疗仅在团体治疗形式中进行过研究。
本研究的目的是对个体加速CBT（aCBT）治疗SAD的疗效进行初步调查。
该研究采用开放试验设计。17名参与者开始接受治疗，治疗包括在4周内进行12次治疗。
结果表明，参与者在治疗后（效应量范围d = 0.76 - 0.92）和3个月随访时（效应量范围d = 1.31 - 1.79）的SAD测量指标上获得了中度至较大的效应量。此外，在治疗后，59%的参与者不再符合SAD的标准，这一数字在3个月随访时增加到71%。
结果提供了初步证据，表明个体aCBT可能是SAD患者的一种重要治疗选择。
